Ticker > Company >

Pramodini Medicare share price

Pramodini Medicare Ltd.

  299   0   0 NSE: PRAMODINI SECTOR: Hospital & Healthcare Services

116.50
+1.70 (1.48%)
NSE: 31 Aug 4:00 PM

Price Summary

Today's High

₹ 116.55

Today's Low

₹ 111.55

52 Week High

₹ 125.95

52 Week Low

₹ 111.55

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationAttractive
The stock is considerably attractive based on intrinsic value.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

256.83 Cr.

Enterprise Value

260.53 Cr.

No. of Shares

2.2 Cr.

P/E

23.36

P/B

2.25

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  51.8

CASH

7.12 Cr.

DEBT

10.81 Cr.

Promoter Holding

-

EPS (TTM)

₹  4.99

Sales Growth

8.54%

ROE

36.48 %

ROCE

40.65%

Profit Growth

60.07 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year8.54%
3 YearNA
5 YearNA

Profit Growth

1 Year60.07%
3 YearNA
5 YearNA

ROE%

1 Year36.48%
3 Year33.05%

ROCE %

1 Year40.65%
3 Year31.86%

Debt/Equity

0.3034

Price to Cash Flow

11.58

Interest Cover Ratio

13.5835

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Investors List
 Share Holding Data is not available for this company.Report us
* Figures given above are % of equity capital

 Strengths

  • Company has been maintaining healthy ROE of 33.0477666666667% over the past 3 years.
  • Company has been maintaining healthy ROCE of 31.8625333333333% over the past 3 years.
  • Company has a healthy Interest coverage ratio of 13.5835.
  • Company’s PEG ratio is 0.0155633725366197.
  • The company has an efficient Cash Conversion Cycle of -156.9253 days.

 Limitations

  • The company has shown a poor profit growth of 0% for the Past 3 years.
  • The company has shown a poor revenue growth of 0% for the Past 3 years.
  • The company has a low EBITDA margin of 0% over the past 5 years.

Quarterly Result (All Figures in Cr.)

 Quarterly Data is not available for this company.Report us

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2023 Mar 2024 Mar 2025
Net Sales 30.58 35.23 38.24
Total Expenditure 16.07 19.9 17.38
Operating Profit 14.51 15.33 20.86
Other Income 0.38 0.56 0.31
Interest 2.21 1.63 1.24
Depreciation 5.36 4.39 4.28
Exceptional Items 0 0 0
Profit Before Tax 7.31 9.87 15.64
Tax 2.04 3 4.64
Net Profit 5.27 6.87 11
Adjusted EPS (Rs.) 3.2 4.11 6.59

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 1.27 1.28 1.28
Total Reserves 16.25 23.36 34.36
Borrowings 12.6 6.22 8.03
Other N/C liabilities -1.17 -1.34 -1.3
Current liabilities 18.24 17.78 12.64
Total Liabilities 47.18 47.3 55.02
Assets
Net Block 20.06 16.03 21.79
Capital WIP 0 0 0
Intangible WIP 0 0 0
Investments 0.38 0.38 0.38
Loans & Advances 4.8 6.32 11.19
Other N/C Assets 0.72 2.19 2.32
Current Assets 21.23 22.39 19.34
Total Assets 47.18 47.3 55.02
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2023 Mar 2024 Mar 2025
Profit from operations 7.31 9.87 15.64
Adjustment 7.36 5.67 5.33
Changes in Assets & Liabilities -4.31 -2.44 5.71
Tax Paid -3.14 -3.1 -4.49
Operating Cash Flow 7.22 10 22.18
Investing Cash Flow -0.85 -0.01 -9.84
Financing Cash Flow -4.19 -12.33 -7.27
Net Cash Flow 2.18 -2.34 5.07

Corporate Actions

Investors Details

 No Promoters Data available for this company.Report us
 No Investors Data available for this company.Report us

Annual Reports

Title Link
Title Link
 No Annual reports exist for this company.Report us

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit and Research reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation and Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Pramodini Medicare Stock Price Analysis and Quick Research Report. Is Pramodini Medicare an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Pramodini Medicare. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Pramodini Medicare has a PE ratio of 23.0156979891337 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Pramodini Medicare has ROA of 21.4933% which is a good sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Pramodini Medicare has a Current ratio of 1.5295.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Pramodini Medicare has a ROE of 36.4801%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Pramodini Medicare has a Debt to Equity ratio of 0.3034 which means that the company has low proportion of debt in its capital.

  • Sales growth: Pramodini Medicare has reported revenue growth of 8.5389% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Pramodini Medicare for the current financial year is 54.5406758251673%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Pramodini Medicare is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Pramodini Medicare is Rs 4.9879. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Pramodini Medicare in Ticker for free. Also, one can get the intrinsic value of Pramodini Medicare by using Valuation Calculators, which are available with a Finology ONE subscription. 

Pramodini Medicare FAQs

Q1. What is Pramodini Medicare share price today?
Ans: The current share price of Pramodini Medicare is Rs 114.8.

Q2. What is the market capitalisation of Pramodini Medicare?
Ans: Pramodini Medicare has a market capitalisation of Rs 253.0834306 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Pramodini Medicare?
Ans: The PE ratio of Pramodini Medicare is 23.0156979891337 and the P/B ratio of Pramodini Medicare is 2.21631890280631, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Pramodini Medicare share?
Ans: The 52-week high share price of Pramodini Medicare is Rs 125.95, and the 52-week low share price of Pramodini Medicare is Rs 114.

Q5. Does Pramodini Medicare pay dividends?
Ans: Currently, Pramodini Medicare does not pay dividends. Dividend yield of Pramodini Medicare is around 0%.

Q6. What are the face value and book value of Pramodini Medicare shares?
Ans: The face value of Pramodini Medicare shares is Rs 10, while the book value per share of Pramodini Medicare is around Rs 51.7976. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Pramodini Medicare?
Ans: Pramodini Medicare has a total debt of Rs 10.8142 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Pramodini Medicare?
Ans: The ROE of Pramodini Medicare is 36.4801% and ROCE of Pramodini Medicare is 40.6513%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Pramodini Medicare a good buy for the long term?
Ans: The Pramodini Medicare long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Pramodini Medicare undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Pramodini Medicare appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Pramodini Medicare’s financials?
Ans: You can review Pramodini Medicare’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Pramodini Medicare
X